233 related articles for article (PubMed ID: 21336117)
1. Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model.
Barkhausen T; Tschernig T; Rosenstiel P; van Griensven M; Vonberg RP; Dorsch M; Mueller-Heine A; Chalaris A; Scheller J; Rose-John S; Seegert D; Krettek C; Waetzig GH
Crit Care Med; 2011 Jun; 39(6):1407-13. PubMed ID: 21336117
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis.
Sodenkamp J; Waetzig GH; Scheller J; Seegert D; Grötzinger J; Rose-John S; Ehlers S; Hölscher C
Immunobiology; 2012 Oct; 217(10):996-1004. PubMed ID: 22387074
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.
Scheller J; Garbers C; Rose-John S
Semin Immunol; 2014 Feb; 26(1):2-12. PubMed ID: 24325804
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-6 trans-signaling improves survival and prevents cognitive impairment in a mouse model of sepsis.
Jiang S; Shi D; Bai L; Niu T; Kang R; Liu Y
Int Immunopharmacol; 2023 Jun; 119():110169. PubMed ID: 37058750
[TBL] [Abstract][Full Text] [Related]
7. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation.
Rose-John S
Clin Pharmacol Ther; 2017 Oct; 102(4):591-598. PubMed ID: 28675418
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
Chalaris A; Schmidt-Arras D; Yamamoto K; Rose-John S
Dig Dis; 2012; 30(5):492-9. PubMed ID: 23108305
[TBL] [Abstract][Full Text] [Related]
10. Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy.
Rodríguez-Hernández MÁ; Baena-Bustos M; Carneros D; Zurita-Palomo C; Muñoz-Pinillos P; Millán J; Padillo FJ; Smerdou C; von Kobbe C; Rose-John S; Bustos M
EBioMedicine; 2024 May; 103():105132. PubMed ID: 38677182
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T
Heise D; Derrac Soria A; Hansen S; Dambietz C; Akbarzadeh M; Berg AF; Waetzig GH; Jones SA; Dvorsky R; Ahmadian MR; Scheller J; Moll JM
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404751
[TBL] [Abstract][Full Text] [Related]
12. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
13. Hitting a complex target: an update on interleukin-6 trans-signalling.
Waetzig GH; Rose-John S
Expert Opin Ther Targets; 2012 Feb; 16(2):225-36. PubMed ID: 22324903
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells.
Valle ML; Dworshak J; Sharma A; Ibrahim AS; Al-Shabrawey M; Sharma S
Exp Eye Res; 2019 Jan; 178():27-36. PubMed ID: 30240585
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-6 trans-signaling in CCl₄induced liver damage.
Gewiese-Rabsch J; Drucker C; Malchow S; Scheller J; Rose-John S
Biochim Biophys Acta; 2010 Nov; 1802(11):1054-61. PubMed ID: 20691261
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma.
Kaiser K; Prystaz K; Vikman A; Haffner-Luntzer M; Bergdolt S; Strauss G; Waetzig GH; Rose-John S; Ignatius A
Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):523-536. PubMed ID: 29497762
[TBL] [Abstract][Full Text] [Related]
17. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice.
Braun O; Dewitz C; Möller-Hackbarth K; Scheller J; Schiffelholz T; Baier PC; Rose-John S
J Interferon Cytokine Res; 2013 May; 33(5):254-60. PubMed ID: 23215755
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 trans-signaling contributes to chronic hypoxia-induced pulmonary hypertension.
Maston LD; Jones DT; Giermakowska W; Resta TC; Ramiro-Diaz J; Howard TA; Jernigan NL; Herbert L; Maurice AA; Gonzalez Bosc LV
Pulm Circ; 2018; 8(3):2045894018780734. PubMed ID: 29767573
[TBL] [Abstract][Full Text] [Related]
19. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
20. The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.
Jeong SJ; Lim BJ; Park S; Choi D; Kim HW; Ku NS; Han SH; Kim CO; Choi JY; Song YG; Kim JM
Inflamm Res; 2012 Nov; 61(11):1211-8. PubMed ID: 22777145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
